RESEARCH REPORT 👉Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors by Jobin Chandi et al. content.iospress.com/articles/bladd… Dr. Bishoy M. Faltas Dan Theodorescu splernerMD

RESEARCH REPORT 👉Effect of Bacille Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer After Prostate Radiotherapy by Adri Durant et al. content.iospress.com/articles/bladd… Dr. Bishoy M. Faltas Dan Theodorescu splernerMD

RESEARCH REPORT 👉Investigating an mRNA-based urine assay (Xpert® Bladder Cancer Detection*) in patients with hematuria – Results from a prospective cohort study by Claudia Schmitz-Dräger et al. content.iospress.com/articles/bladd… Dr. Bishoy M. Faltas Dan Theodorescu splernerMD

Timely and clinically relevant review of commercially available noninvasive tests for detection and surveillance of bladder cancer. 👇 Dr. Bishoy M. Faltas Dan Theodorescu splernerMD

SYSTEMATIC REVIEW 👉Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available Assays 👈 by John R. Heard, MD, MS Anirban Mitra Cedars-Sinai Cancer at Cedars-Sinai Cedars-SinaiMed content.iospress.com/articles/bladd… Dr. Bishoy M. Faltas Dan Theodorescu splernerMD

SYSTEMATIC REVIEW 👉Efficacy of Antibody Drug Conjugates Alone and in Combination with other Agents in Metastatic Urothelial Carcinoma: A Scoping Review by @mjgrantmd et al. content.iospress.com/articles/bladd… Dr. Bishoy M. Faltas Dan Theodorescu splernerMD

❗ New Cheat Sheet on MIBC: Disease Management.

It discusses various strategies for urinary diversion following radical cystectomy, highlighting the use of the ileum, colon, and appendix.

Download here:
uroweb.org/guidelines/mus…

#EAUguidelines #BladderCancer

Happy to share our commentary about EV-302 European Urology European Association of Urology (EAU) - Thanks to Niklas Klümper Boris Hadaschik Viktor Grünwald

Identification of patients with low or minimal chances of benefiting from EV/P is crucial, as there are other effective therapies available (eg,…

Data from the control arm of adjuvant bladder cancer trials (CM274 and Ambassador250) suggests ~35% get no further therapy after relapse (accounting for censoring). Excellent sites. Chemo is globally available. Regular CT follow should catch early & treat. Any easy explanations?

“Entscheidungshilfe Prostatakrebs” by #DGU and #USG might improve shared decision-making and time efficiency: 11,290 patients and 91 urologists in Germany evaluate an online #prostatecancer patient decision aid reporting high acceptance and satisfaction
doi.org/10.1111/bju.16…

Online now: Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC
Constantin Rieger

doi.org/10.1111/bju.16…

RESEARCH REPORT 👉 Evaluation of opium on the expression of SOX2 and OCT4 in wistar rat bladder by Iman Menbari Oskouie et al. content.iospress.com/articles/bladd… Dan Theodorescu Dr. Bishoy M. Faltas splernerMD

Great commentary for the 3D spatial profiling in cancer research 👉doi.org/10.1158/2159-8…

Urologists, you’ll never walk alone!
#NMIBC #bladdercancer
sciencedirect.com/science/articl…

Andrea Necchi & I are extremely grateful to Neeraj Agarwal, MD, FASCO Andrea Apolo, M.D. alberto briganti Petros Grivas Shilpa Gupta Ashish M. Kamat, MD, MBBS Francesco Montorsi Morgan Roupret for having supported our idea now on European Urology Oncology

In this new #OpenAccess review, Likhitha Kolla and Ravi B. Parikh discuss uses and limitations of AI for oncology in areas ranging from diagnosis to prognosis to generative AI and patient communication.

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert